| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 33 |
| 1 | METHOTREXATE | 32 |
| 2 | ADALIMUMAB | 26 |
| 3 | LISINOPRIL | 26 |
| 4 | DEXAMETHASONE | 25 |
| 5 | DEXAMETHASONE 1.5 MG | 25 |
| 6 | PREDNISOLONE | 24 |
| 7 | PREDNISOLONE ORAL | 24 |
| 8 | PREDNISOLONE ORAL SOLUTION | 24 |
| 9 | CYTARABINE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MAGESIUM CITRATE | 1 | 0.0109 |
| 1 | BENZNIDAZOLE | 1 | 0.0098 |
| 2 | PURIXAN | 2 | 0.0026 |
| 3 | ADEFOVIR DIPIVOXIL | 3 | 0.0024 |
| 4 | PONATINIB HYDROCHLORIDE | 11 | 0.0021 |
| 5 | PEGASPARGASE | 21 | 0.0017 |
| 6 | INSULIN LISPRO-AABC | 2 | 0.0009 |
| 7 | GARLIC | 4 | 0.0009 |
| 8 | ELRANATAMAB-BCMM | 1 | 0.0009 |
| 9 | CEFOXITIN SODIUM | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 46 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 32 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 27 |
| 4 | Alkylating Drug [EPC] | 22 |
| 5 | Azole Antifungal [EPC] | 22 |
| 6 | beta-Adrenergic Blocker [EPC] | 22 |
| 7 | Asparagine-specific Enzyme [EPC] | 21 |
| 8 | alpha-Adrenergic Blocker [EPC] | 19 |
| 9 | Opioid Agonist [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 21 | 0.0016 |
| 1 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 4 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 5 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 7 | Complement 5a Receptor Antagonist [EPC] | 2 | 0.0003 |
| 8 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 9 | Anti-coagulant [EPC] | 1 | 0.0003 |